(Q35848146)

10 August 2017

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma (English)

1 reference

10 August 2017

1 reference

4

Angela Dispenzieri

1 reference

10 August 2017

13

Robert A Kyle

1 reference

10 August 2017

3

Martha Q Lacy

1 reference

10 August 2017

12

Stephen J Russell

1 reference

10 August 2017

1

S Vincent Rajkumar

1 reference

10 August 2017

15

Morie A Gertz

1 reference

10 August 2017

2

Suzanne R Hayman

1 reference

10 August 2017

7

Steven R Zeldenrust

1 reference

10 August 2017

11

John A Lust

1 reference

10 August 2017

8

Shaji Kumar

1 reference

10 August 2017

14

Thomas E Witzig

1 reference

10 August 2017

9

Philip R Greipp

1 reference

10 August 2017

5

Susan M Geyer

1 reference

10 August 2017

6

Brian Kabat

1 reference

10 August 2017

Rafael Fonseca

10

1 reference

PMCID

1895238

10 August 2017

language of work or name

English

0 references

publication date

23 August 2005

1 reference

10 August 2017

1 reference

10 August 2017

106

1 reference

10 August 2017

13

1 reference

10 August 2017

4050-4053

1 reference

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Treatment of plasma cell dyscrasias with thalidomide and its derivatives

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

VAD-based regimens as primary treatment for multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Primary dexamethasone treatment of multiple myeloma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1895238

24 September 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16118317

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16118317

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16118317

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2005-07-2817

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

PMCID

1895238